Response to Letters regarding "Risk and Benefit of mRNA COVID-19 Vaccines for the Omicron Variant by Age, Sex, and Presence of Comorbidity: A Quality-Adjusted Life Years Analysis"
Am J Epidemiol. 2023 Dec 19:kwad243.
doi: 10.1093/aje/kwad243.
Online ahead of print.